Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitelliform Macular Dystrophy | 1 | 2024 | 18 | 0.910 |
Why?
|
Amelogenesis Imperfecta | 1 | 2023 | 4 | 0.870 |
Why?
|
Retinal Neoplasms | 1 | 2024 | 146 | 0.790 |
Why?
|
Cell-Penetrating Peptides | 1 | 2022 | 49 | 0.780 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 273 | 0.750 |
Why?
|
Vitreous Body | 2 | 2024 | 399 | 0.700 |
Why?
|
Diabetic Retinopathy | 4 | 2024 | 1268 | 0.650 |
Why?
|
Retinitis Pigmentosa | 1 | 2020 | 397 | 0.550 |
Why?
|
Apolipoproteins A | 1 | 2016 | 95 | 0.540 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 829 | 0.530 |
Why?
|
Cataract | 3 | 2021 | 827 | 0.530 |
Why?
|
Directed Molecular Evolution | 1 | 2016 | 158 | 0.510 |
Why?
|
Visual Acuity | 5 | 2024 | 2643 | 0.500 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2884 | 0.480 |
Why?
|
Angiogenesis Inhibitors | 4 | 2021 | 2049 | 0.470 |
Why?
|
Fluorescein Angiography | 4 | 2024 | 1045 | 0.470 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1403 | 0.450 |
Why?
|
Connexins | 1 | 2015 | 351 | 0.440 |
Why?
|
Phacoemulsification | 1 | 2014 | 149 | 0.420 |
Why?
|
Oligopeptides | 1 | 2016 | 1187 | 0.370 |
Why?
|
Macular Degeneration | 3 | 2024 | 1002 | 0.360 |
Why?
|
Mutation, Missense | 2 | 2020 | 2567 | 0.350 |
Why?
|
Glycoproteins | 1 | 2017 | 2208 | 0.340 |
Why?
|
Disease Progression | 2 | 2024 | 13505 | 0.330 |
Why?
|
Microsurgery | 1 | 2014 | 796 | 0.320 |
Why?
|
Diagnostic Imaging | 1 | 2023 | 3527 | 0.310 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1186 | 0.290 |
Why?
|
Retinal Diseases | 2 | 2023 | 702 | 0.270 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1021 | 0.260 |
Why?
|
Peptide Fragments | 1 | 2016 | 5132 | 0.230 |
Why?
|
Visually Impaired Persons | 1 | 2023 | 78 | 0.210 |
Why?
|
Oligomycins | 1 | 2022 | 20 | 0.200 |
Why?
|
Cytochalasin D | 1 | 2022 | 91 | 0.200 |
Why?
|
Vitrectomy | 3 | 2023 | 391 | 0.200 |
Why?
|
Transcytosis | 1 | 2022 | 45 | 0.200 |
Why?
|
Aniridia | 1 | 2021 | 36 | 0.200 |
Why?
|
Kringles | 1 | 2021 | 8 | 0.190 |
Why?
|
Vision, Low | 1 | 2023 | 163 | 0.190 |
Why?
|
Cations | 1 | 2022 | 239 | 0.190 |
Why?
|
Retina | 2 | 2023 | 2635 | 0.190 |
Why?
|
Eye Proteins | 2 | 2021 | 633 | 0.190 |
Why?
|
Growth Inhibitors | 1 | 2021 | 378 | 0.180 |
Why?
|
Anesthesia, Conduction | 1 | 2022 | 261 | 0.160 |
Why?
|
Peptides | 2 | 2021 | 4354 | 0.160 |
Why?
|
Retinal Detachment | 1 | 2023 | 427 | 0.150 |
Why?
|
Endocytosis | 1 | 2022 | 959 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 435 | 0.150 |
Why?
|
Injections, Intraocular | 1 | 2016 | 33 | 0.140 |
Why?
|
Ubiquitination | 1 | 2021 | 1008 | 0.140 |
Why?
|
Nerve Block | 1 | 2022 | 688 | 0.130 |
Why?
|
RNA Splicing | 1 | 2020 | 915 | 0.130 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 1993 | 0.130 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 666 | 0.120 |
Why?
|
Photometry | 1 | 2014 | 56 | 0.120 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2015 | 426 | 0.120 |
Why?
|
Astigmatism | 1 | 2014 | 68 | 0.120 |
Why?
|
ROC Curve | 2 | 2022 | 3568 | 0.110 |
Why?
|
Neovascularization, Pathologic | 2 | 2021 | 2640 | 0.110 |
Why?
|
China | 2 | 2021 | 2339 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2023 | 15679 | 0.110 |
Why?
|
Lens Implantation, Intraocular | 1 | 2014 | 190 | 0.100 |
Why?
|
Blotting, Western | 2 | 2021 | 5039 | 0.100 |
Why?
|
Pedigree | 2 | 2021 | 4578 | 0.100 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1229 | 0.100 |
Why?
|
Animals, Newborn | 1 | 2016 | 2671 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3802 | 0.090 |
Why?
|
Glucose | 1 | 2021 | 4350 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4434 | 0.080 |
Why?
|
Chick Embryo | 2 | 2021 | 981 | 0.080 |
Why?
|
Humans | 17 | 2024 | 760613 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2022 | 4938 | 0.080 |
Why?
|
Intravitreal Injections | 2 | 2021 | 384 | 0.080 |
Why?
|
Transfection | 1 | 2015 | 5781 | 0.070 |
Why?
|
Male | 7 | 2024 | 359718 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4108 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22020 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8158 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5890 | 0.060 |
Why?
|
Female | 7 | 2024 | 391246 | 0.060 |
Why?
|
Base Sequence | 1 | 2015 | 12444 | 0.060 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13451 | 0.050 |
Why?
|
Middle Aged | 4 | 2020 | 220359 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3617 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10343 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17624 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8595 | 0.050 |
Why?
|
Angiopoietin-1 | 1 | 2022 | 122 | 0.050 |
Why?
|
Choroid | 1 | 2024 | 349 | 0.050 |
Why?
|
Diazepam | 1 | 2022 | 215 | 0.050 |
Why?
|
Chorioallantoic Membrane | 1 | 2021 | 50 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25941 | 0.050 |
Why?
|
Rats | 1 | 2016 | 23709 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2021 | 748 | 0.040 |
Why?
|
Blindness | 1 | 2023 | 582 | 0.040 |
Why?
|
Oxygen | 2 | 2021 | 4193 | 0.040 |
Why?
|
Serpins | 1 | 2021 | 247 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39262 | 0.040 |
Why?
|
Cell Movement | 2 | 2021 | 5206 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2021 | 290 | 0.040 |
Why?
|
Chickens | 1 | 2021 | 860 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2021 | 562 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2024 | 836 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12289 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2023 | 80345 | 0.040 |
Why?
|
Mice | 3 | 2021 | 81209 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 29661 | 0.030 |
Why?
|
Vision Disorders | 1 | 2023 | 1084 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 87809 | 0.030 |
Why?
|
Cell Death | 1 | 2021 | 1671 | 0.030 |
Why?
|
Adult | 3 | 2023 | 220007 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2021 | 10442 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 64981 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54306 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2138 | 0.030 |
Why?
|
Animals | 3 | 2021 | 167960 | 0.020 |
Why?
|
Aged | 3 | 2023 | 169143 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3484 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2014 | 58980 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 58748 | 0.020 |
Why?
|
Child | 1 | 2015 | 79799 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8525 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15686 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18955 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18137 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40139 | 0.010 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_